Specifically, in the context of TNBCs, the expression of CD44 is linked to cancer stemness and linearly correlates with the amount of breast Cancer Stem Cells (CSCs) characterized by the CD44high/CD24low immunophenotype. Here, CD44 is linked to breast cancer.